The effectiveness of the TOSI reporter in drug screening underscores the importance of inhibitors that restrict mycobacterial growth, thereby underlining the growing relevance of PDCD4 in bacterial infections and indicating promising avenues for future therapeutic developments. Here, PDCD4 is linked to bacterial infectious disease.